🧠 Ask this record

Get an AI answer drawn only from the NIH Pandemic-Era Grants documents indexed here — every claim cited back to the filing or proceeding it came from. It will tell you plainly when the record doesn't cover your question, rather than guessing.

9873 documents

ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Tejal A. Desai · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2023 · $805,361 — PROJECT SUMMARY: The COVID-19 pandemic, caused by the new coronavirus SARS-CoV-2, has had a remarkable impact on public health worldwide with the largest number of cases and deaths reported in the United States. Improved understanding of COVID-19 will accelerate the development of effective therapeu…

Structure of HIV-1 envelope spike in the context of membrane

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Bing Chen · BOSTON CHILDREN'S HOSPITAL · 2023 · $531,000 — Project Summary Membrane fusion, mediated by HIV-1 envelope glycoprotein [Env; trimeric (gp160)3 cleaved to (gp120/gp41)3], is the first critical step for the virus to enter host cells and establish infection. A mature Env spike contains three copies each of noncovalently-associated receptor-binding…

COVID-19: Elucidating monoclonal and polyclonal seroantibody responses to the COVID-19 viral envelope

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Mohammad Mohseni Sajadi · BALTIMORE VA MEDICAL CENTER · 2023 — Background/Rationale: As the Coronavirus Disease 2019 (COVID-19) epidemic expands across the United States and the world, there are no proven therapies and little information is known regarding on immunity to this virus. At this stage of the pandemic, all prevention and treatment strategies that sho…

Double-Encapsulated mRNA Vaccine for COVID-19

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

TREVOR P. CASTOR · APHIOS CORPORATION · 2023 · $300,000 — PROJECT SUMMARY COVID-19, the multiorgan disease caused by the novel coronavirus SARS-CoV-2, has become the most impactful healthcare, social, and economic crisis of our lifetime. SARS-CoV-2 is genetically related to the previous two coronaviruses that caused human outbreaks in the 21st century, SAR…

Investigating the role and therapeutic potential of the alpha5beta1 integrin in risk factors for COVID-19-associated cognitive impairment

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

TIONE BURANDA · TULANE UNIVERSITY OF LOUISIANA · 2023 · $2,254,100 — ABSTRACT Rapidly emerging evidence has characterized the association between vascular dementia (VaD) and increased COVID-19 incidence, morbidity, and post-COVID cognitive decline. We theorize that brain vascular pathology in VaD and additional pathophysiologic features such as blood-brain barrier (B…

Development of pan-betacoronavirus vaccines

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Raiees Ahmad Andrabi · SCRIPPS RESEARCH INSTITUTE, THE · 2023 · $805,612 — PROJECT SUMMARY/ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus identified at the end of 2019, has led to the current global pandemic. The SARS-CoV-2 virus belongs to the subgenus sarbecovirus of the genus betacoronavirus, the genus from which two SARS-CoV-…

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

DAVID BAKER · UNIVERSITY OF WASHINGTON · 2023 · $703,773 — PROJECT SUMMARY One of the most pressing public health priorities for the COVID-19 pandemic is the development of an effective and inexpensive therapeutic. The long-term goal of this proposal is to develop such COVID-19 treatments, as well as the methods needed to rapidly create such molecules as so…

Genetic and Molecular Basis of Longevity

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

GARY B RUVKUN · MASSACHUSETTS GENERAL HOSPITAL · 2023 · $431,960 — Project Summary/Abstract: Our discovery that the NGLY1/PNG-1 deglycosylation enzyme mediates the protein editing of N- glycosylated asparagines to aspartic acid of the SKN-1A transcription factor to increase proteasomal capacity is highly relevant to protein aggregation diseases, such as Alzheimer’s…

Identification and characterization of novel functions for the Usher proteins in the inner ear

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Marisa L. Zallocchi · CREIGHTON UNIVERSITY · 2023 · $520,111 — ABSTRACT. An organism’s perception of its surrounding environment depends on the sensory function. Neurosensory cells from the inner ear are involved in key biological processes associated with hearing and balance. To be able to achieve their function these cells depend on a complex array of membran…

Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Ivan Zanoni · BOSTON CHILDREN'S HOSPITAL · 2023 · $748,825 — PROJECT SUMMARY Vaccines represent a highly effective public health measure to protect individuals from infectious diseases. Many vaccines work by inducing antigen-specific antibodies that neutralize the pathogen or its products and promote their clearance. Vaccines based on protein antigens usually…

High-Throughput, Rapid, and Epitope-Specific Quantification of Neutralizing Antibodies Using Digital Nanoparticle Sensors

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Chao Wang · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · 2023 · $189,242 — Project Summary/Abstract As of mid June 2021, the new coronavirus disease (COVID-19), caused by SARS-CoV-2 virus, has infected ~180 million people and causing ~3.8 million deaths globally. There are more than 34 million confirmed cases and ~620,000 deaths in the U.S alone. The fast transmission, as…

Functionalized lipid inactosomes to bind and clear SARS-CoV-2

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Daniel A Hammer · UNIVERSITY OF PENNSYLVANIA · 2023 · $203,125 — Summary Severe respiratory acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19, a world-wide pandemic causing over 525K deaths in the U.S. and over 2.6M deaths world-wide as of this writing. Here, we propose to make phospholipid vesicles and other related nanostructures (d…

SARS-CoV-2 vaccine durability during SIV infection

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Megan A O'Connor · UNIVERSITY OF WASHINGTON · 2023 · $353,000 — PROJECT SUMMARY/ABSTRACT COVID-19 vaccination is safe, immunogenic, and durable in individuals with treated and virally suppressed HIV infection but is less immunogenic in immunosuppressed individuals and those with unsuppressed HIV infection. The rollout of COVID-19 vaccines is still limited in cou…

Transmission of CoV-2 and the Impact of Spike Protein Evolution

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Adrianus CM Boon · WASHINGTON UNIVERSITY · 2023 · $581,630 — PROJECT SUMMARY SARS-CoV-2 has led to unprecedented disruptions to society, killing more than 6 million people worldwide. It is a respiratory virus whose main mode of transmission is via respiratory droplets and aerosols. Social distancing and vaccines have greatly decreased the rate of infection an…

Mechanism of Rotavirus Entry

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Siyuan Ding · WASHINGTON UNIVERSITY · 2023 · $233,250 — Rotavirus (RV) is a major etiological cause of severe gastroenteritis and diarrhea worldwide, resulting in the death of more than 200,000 children each year. Current RV vaccines have limited efficacy in endemic countries and no direct antivirals are available. Our overall objective is to better unde…

Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Amit Praful Khandhar · HDT BIO CORPORATION · 2023 · $940,253 — Project Summary/Abstract A key requirement for HIV-1 vaccine development is the induction of broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope (Env) spike. The BG505 SOSIP.664 gp140 soluble timer is engineered to display conformational epitopes recognized by several bNAbs but not …

Role of CACHD1 in the development of temporal lobe epilepsy and absence epilepsy

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

MANOJ K PATEL · UNIVERSITY OF VIRGINIA · 2023 · $399,015 — Epilepsy is a major economic and personal burden for the American public, affecting over 3 million Americans (1-2% of the population) with over 200,000 new cases diagnosed each year. There is no cure for epilepsy. Seizures can only be suppressed using antiepileptic drugs. Unfortunately, these drugs …

Viral Vectored COVID-19 Vaccines in a Guinea Pig Perinatal Infection Model

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

YUYING LIANG · UNIVERSITY OF MINNESOTA · 2023 · $232,500 — Abstract The COVID-19 pandemic has had a profound, global impact on public health. Of the 120,000,000 cases documented world-wide, over 30 million cases have occurred in the Unites States, with >530,000 COVID deaths to date. Considerable progress in control of the pandemic has been realized in the U…

Clonal Dynamics of the antibody response

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Gabriel D Victora · ROCKEFELLER UNIVERSITY · 2023 · $628,260 — PROJECT SUMMARY Generating an appropriate antibody response is critical for protection against reinfection and for the effectiveness of vaccination, particularly in the context of viral diseases. In addition to well-studied quantitative parameters such as antibody titer and affinity, other, more qua…

Structural studies of viral replication and invasion

NIH Pandemic-Era Grants · Pandemic Era Grants / 2023

Hideki Aihara · UNIVERSITY OF MINNESOTA · 2023 · $619,646 — Abstract Viruses are a major threat to human health. Our laboratory uses various structural biology techniques to dissect molecular mechanisms of how viruses replicate and invade the host cell or its genome. One area of our major interest is retroviral integration, a critical step in the lifecycle o…